Clinical updates, including trial initiations, enrollment status and data readouts and publications: Nextbiomedical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biohaven, Corestemchemon, Keros, Moderna, Neurocrine, Oric, Pepgen, Taysha, Uniqure.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biohaven, Cumberland, EMD Serono, Evommune, GSK, Inflarx, Irlab, Octapharma, Ono, Spero, Strand, Veru.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Asklepios, Bayer, Bioxcel, Gilgamesh, Immutep, Innovent, Invivyd, Iolyx, Mineralys, Palisade, Rocket.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neuropace, Seekin.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bicara, Gilead, Gyre, Immix, Imunon, Innate, Merus, Roche.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Accro, Annji, Astrazeneca, Brii, Cytora, Telix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiawave.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annji, Aurinia,Insmed, Revalesio, Satellos.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cytosorbents, Edwards, Hoya Vision, Mission Bio, Sea-Band, Tricares.